Mandelic Acid

Mandelic Acid

SCHEMBL21383946

NCCCCC(N)C(=O)O.O=C(O)C(O)c1ccccc1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Mandelic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.62
▸ LMNA P02545 2/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ POLB P06746 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ DPP8 Q6V1X1 1/20 0.48
▸ DPP9 Q86TI2 1/20 0.48
▸ DPP7 Q9UHL4 1/20 0.48
▸ MMP2 P08253 1/20 0.47
▸ GRM2 Q14416 2/20 0.47
▸ GRM3 Q14832 2/20 0.47
▸ HTR2A P28223 1/20 0.44
▸ HRH1 P35367 1/20 0.44
▸ KIF11 P52732 3/20 0.44
▸ THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mandelic Acid SCHEMBL9393798 0.88 LMNA (0.72) LMNAMAPK1HTR2AHRH1
Aminodiphenylmethane SCHEMBL23925166 0.87 GSR (0.67) GSRPOLBKMT2ATDP1DPP8
Aminodiphenylmethane SCHEMBL14167635 0.87 GSR (0.67) GSRPOLBKMT2ATDP1DPP8
Diphenylacetic Acid SCHEMBL10358556 0.86 GSR (0.65) GSRPOLBKMT2ATDP1DPP8
Phenylglycine SCHEMBL23629659 0.86 GSR (0.65) GSRPOLBKMT2ATDP1DPP8
Lysine SCHEMBL29438093 0.83 GSR (0.61) GSRPOLBKMT2ATDP1DPP8
Lysine SCHEMBL28214073 0.83 GSR (0.91) GSRPOLBKMT2ATDP1DPP8
Lysine SCHEMBL28553383 0.82 SRC (0.61) GSRPOLBKMT2ATDP1DPP8
Lysine SCHEMBL28249818 0.82 GSR (0.69) GSRPOLBKMT2ATDP1DPP8
Lysine SCHEMBL28249816 0.82 GSR (0.69) GSRPOLBKMT2ATDP1DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019183385-A1 MAPK/ERK INHIBITION FOR OVARIAN AND OTHER CANCERS UNIVERSITY OF ROCHESTER (US) 2019-09-26 — — WO disclosed
Send feedback